Company Overview and News

0
HUL Q1 results today. Here is what to expect

2018-07-16 livemint
Hindustan Unilever Ltd (HUL), India’s largest listed consumer packaged goods firm by sales, will announce its results for the June 2018 quarter today. A Bloomberg poll of 15 analysts has estimated HUL’s Q1 profit at Rs 1,540 crore and revenues at Rs 9,669 crore. This is the second quarter in a row that the India unit of Unilever Plc has witnessed high raw material inflation. Crude at $78 for a barrel remains firm.
UL UN UNLYF ULVR 500696 HINDUNILVR UNLNF

0
PRESS DIGEST- Financial Times - July 13

2018-07-13 reuters
July 13 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
BT.A UL UN UNLYF ULVR BTGOF UNLNF BT

0
P&G says 'vast majority' of products in Canada to be hit by tariffs

2018-07-12 theedgemarkets
CHICAGO (July 12): Many Procter & Gamble Co products sold in Canada — from Febreze candles to Gillette shaving foam — will be affected by retaliatory tariffs on US-made goods after Canadian authorities rejected a request for exemptions, a P&G spokesman said on Wednesday.
UL UN UNLYF ULVR UNLNF

0
P&G says 'vast majority' of products in Canada to be hit by tariffs

2018-07-12 reuters
CHICAGO (Reuters) - Many Procter & Gamble Co (PG.N) products sold in Canada - from Febreze candles to Gillette shaving foam - will be affected by retaliatory tariffs on U.S.-made goods after Canadian authorities rejected a request for exemptions, a P&G spokesman said on Wednesday.
UL UN UNLYF ULVR UNLNF

0
BASF Playing China Matchmaker Should Worry U.S. - Bloomberg

2018-07-12 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
STAN BNPQY ULVR OGZD UNLNF HSB STAB STAC SCBFF STAN BFFAF HSBC.PRA HSBC SYT HBCYF HCS.PRB UL UN UNLYF BNPQF DDAIF HCS SYENF VLKAF 0005 BNPZY 580001 2888 HSEA HSEB BASFY BFA 81JK

7
Twitter Follower Numbers to Drop as It Removed Locked Accounts - WSJ

2018-07-11 wsj
Twitter Inc. TWTR 0.27% said it is subtracting some accounts it has flagged for suspicious activity from the follower numbers of its hundreds of millions of users, part of the social-media company’s efforts to clamp down on abusive activity.
UL UN UNLYF ULVR TWTR UNLNF

0
With stunts and viral videos, more brands turn to social media ‘influencer’ marketing

2018-07-04 japantimes.co.jp
LONDON/CANNES, FRANCE – This spring, Pernod Ricard SA’s Malibu Rum paid American singer Nick Jonas to host a competition in Vietnam that began with 33 Instagram stars battling to catch fake pineapples while flying off a giant waterslide into the sea.
UL UN PUB UNLYF ULVR OMC RI UNLNF

0
Big food firms Nestle, Hershey at odds with farmers over US GMO labeling

2018-07-03 channelnewsasia
The world's top food companies and farmers of crops such as beet sugar are pitted against each other as they lobby the U.S. government over plans to label genetically-engineered ingredients.
DANOY BN HSYFB UL UN UNLYF ULVR GPDNF UNLNF HSY

0
Big food firms Nestle, Hershey at odds with farmers over U.S. GMO labeling

2018-07-03 reuters
NEW YORK (Reuters) - The world’s top food companies and farmers of crops such as beet sugar are pitted against each other as they lobby the U.S. government over plans to label genetically-engineered ingredients.
DANOY BN HSYFB UL UN UNLYF ULVR GPDNF UNLNF HSY

24
Nike needs ‘real’ people — not just Serena Williams — to sell to women - MarketWatch

2018-07-02 marketwatch
‘Real women’ and social media ‘microinfluencers’ may be key to targeting a female demographic, say analysts
UL NKE UN UNLYF ULVR AEO LULU UNLNF

2
HUL raises stakes in battle against trademark violation

2018-07-02 livemint
Mumbai: Hindustan Unilever Ltd (HUL) has increased its firepower against copycats more than ever before, and smaller players are feeling the heat, be it small businesses in Assam, Gujarat, Jodhpur in Rajasthan or Jalpaiguri in West Bengal.
UL UN UNLYF ULVR 500696 HINDUNILVR UNLNF

2
Twitter makes big change to fight against abuse and fake accounts

2018-06-26 smh.com.au
Twitter said it's making changes to combat abuse and malicious automated accounts, including requiring more authentication for new users, in an effort to address complaints that social networking services have allowed harassment and manipulation to run rampant.
UL UN UNLYF ULVR UNLNF

23
Twitter Ramps Up Fight Against Abuse and Malicious Bots - Bloomberg

2018-06-26 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
UL UN UNLYF ULVR TWTR UNLNF

2
Rising crime pushes Mexico bulletproof car production to record | Euronews

2018-06-26 euronews
MEXICO CITY (Reuters) – Historic levels of violent crime in Mexico have sparked a record increase in the country’s car-armouring business, with an industry group predicting a double-digit jump in the number of vehicles bulletproofed this year.
UL UN UNLYF ULVR UNLNF

2
Rising crime pushes Mexico bulletproof car production to record

2018-06-26 reuters
MEXICO CITY, June 25 (Reuters) - Historic levels of violent crime in Mexico have sparked a record increase in the country’s car-armoring business, with an industry group predicting a double-digit jump in the number of vehicles bulletproofed this year.
UL UN UNLYF ULVR UNLNF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

46m - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

22h - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...